43 Prevalence of secondary prevention medication use in South America 2 94. Koopman C, Vaartjes I, Heintjes EM, Spiering W, Dis I, Herings RMC, et al. Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010. Eur Heart J. 2013;34(41):3198–205. 95. Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Women’s Heal. 2014;23(2):112–9. 96. Barrett E, Paige E, Welsh J, Korda RJ, Joshy G, Martin M, et al. Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study. Prev Med Reports. 2021;22:101342. 97. Redfors B. Women Are Less Likely to Get Secondary Prevention Medications and Cardiac Rehabilitation. Clinical Topics. American College of Cardiology. 2017 [cited 2022 Feb 24].
RkJQdWJsaXNoZXIy MTk4NDMw